Filana Therapeutics, Inc.
FLNA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001069530
No open-market purchases or sales by Filana Therapeutics, Inc. insiders were filed in the last 90 days; 85 institutions reported holding it in 13F filings for Q2 2026, worth $15.1M in total; no superinvestor holds it.
Holders of 5% or more of FLNA
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Filana Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Filana Therapeutics, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
13 Schedule 13D and 13G filings on Filana Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Jul 29, 202511:22 AM ET | Vanguard Group Inc | 13G/A | 4.49%2.17M shares | –Below 5% | Jun 30, 2025 | SEC |
| Jul 16, 20257:02 PM ET | BlackRock, Inc. | 13G/A | 3.20%1.55M shares | –Below 5% | Jun 30, 2025 | SEC |
| Nov 26, 20244:48 PM ET | Nachtrab Matthew | 13G/A | 4.70%2.27M shares | −0.70 ppfrom 5.40%Below 5% | Aug 16, 2024 | SEC |
| Aug 21, 202412:47 PM ET | Nachtrab Matthew | 13G | 5.40%2.60M shares | New | Aug 16, 2024 | SEC |
| Feb 9, 2022 | Vanguard Group Inc | 13GOld format | – | New | – | SEC |
| Feb 3, 20225:05 PM ET | Barbier Remi | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Barbier Remi | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | CVI Investments, Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2021 | Satterfield Thomas A Jr | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2021 | Renaissance Technologies LLC | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2021 | Hudson Bay Capital Management LP | 13G/AOld format | – | – | – | SEC |
| Feb 5, 20215:01 PM ET | BlackRock Inc. | 13GOld format | – | – | – | SEC |
| Feb 2, 20213:13 PM ET | BlackRock Inc. | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Filana Therapeutics, Inc. shares.
No Form 144 notices for Filana Therapeutics, Inc. are on file.